
A Prospective, observational, Italian multi-center registry of self-aPposing® cOronary Stents in patients presenting with ST-segment Elevation Myocardial InfarcTION: The iPOSITION registry
Author(s) -
Livio Giuliani,
Federico Archilletti,
Giuseppe Andò,
Serena Rossi,
Giorgio Sacchetta,
Giuseppe De Iaco,
Francesco Saporito,
Marco Contarini,
Rosario Parisi,
Sabina Gallina,
Marco Zimarino,
Juan Luis GutiérrezChico,
Nicola Maddestra
Publication year - 2021
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2021.0045
Subject(s) - medicine , myocardial infarction , cardiology , percutaneous coronary intervention , clinical endpoint , stent , target lesion , clinical trial
Primary percutaneous coronary intervention (pPCI) in ST-segment elevation myocardial infarction (STEMI) can be challenging for high thrombus burden and catecholamine-induced vasoconstriction. The Xposition-S stent was designed to prevent stent undersizing and minimize strut malapposition. We evaluated 1-year clinical outcomes of a nitinol, self-apposing®, sirolimus-eluting stent, pre-mounted on a novel balloon delivery system, in de novo lesions of patients presenting with STEMI undergoing pPCI.